QTTB
Q32 Bio Inc
8.40$
+1.7%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
Q32 Bio Inc (QTTB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -3.1 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22 | -11 | -9.7 | -14 | -8.1 | -18 | -22 | -25 | -26 | -26 | -28 | -29 | -12 | -30 | -24 | -25 | -30 | -31 | -31 | -25 | 9.5 | -12 | 2.2 | 16 | -11 | -15 | -22 | -20 | -11 | -12 | -11 | -4.2 | -6.2 | -6.3 | -3.1 | -20 | |
| 0.2 | 0.2 | 0.2 | 0.3 | 0.6 | 1.3 | 1.6 | 1.7 | 1.7 | 2.1 | 2.2 | 2.2 | 2.3 | 2.4 | 2.4 | 2.4 | 2.4 | 0.5 | 0.8 | 0.6 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.4 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 1.3 | 1.4 | 1.3 | 1.3 | 1.3 | 1.2 | 1.5 | 1.5 | 1.7 | 5.9 | |
| 34 | -1.0 | 2.1 | 0.6 | 10 | 4.1 | 1.5 | 0.9 | -6.1 | 4.6 | 1.7 | -6.2 | 11 | -35 | -0.7 | -1.7 | -4.3 | 3.2 | -6.9 | 4.0 | 17 | -6.3 | -9.1 | 23 | 14 | -0.6 | -6.8 | -3.3 | 1.0 | -2.2 | -3.3 | 1.7 | -0.2 | -0.6 | 3.2 | 4.1 | |
| 0.3 | 1.0 | 3.1 | 4.8 | 16 | 10 | 5.9 | 1.7 | 3.7 | 2.0 | 0.6 | 0.2 | 1.0 | 0.8 | 0.8 | 0.5 | 0.3 | 1.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -80 | 6.6 | -93 | -45 | 10 | 20 | -38 | -13 | -20 | 115 | 52 | 39 | -1.0 | -85 | -14 | 4.5 | 44 | 168 | -41 | -108 | 0.0 | 0.0 | -31 | 0.0 | 32 | 0.1 | 9.9 | 9.9 | 0.0 | – | 0.0 | – | 7.0 | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | -1.6 | -1.6 | -1.6 | -8.3 | -13 | |
| 12 | -1.0 | 152 | 0.0 | 0.0 | 0.3 | 135 | 0.6 | 23 | 0.4 | 0.2 | 0.4 | 52 | 2.0 | 50 | 0.4 | 0.0 | 0.4 | 0.1 | 0.1 | 17 | 0.0 | -0.1 | 0.3 | 0.1 | 99 | -5.5 | 1.0 | 0.3 | 0.0 | -0.3 | -1.6 | -1.6 | 8.8 | 59 | 64 | |
| – | – | – | – | – | – | – | – | -24 | 90 | 24 | 10 | 39 | -113 | 12 | -20 | 13 | 140 | -72 | -133 | 26 | -12 | 37 | -48 | -3.5 | 85 | -18 | -8.6 | -11 | -12 | -11 | -5.8 | -0.7 | 2.5 | 56 | 51 | |
| 22 | -12 | -13 | -19 | -24 | -28 | -28 | -27 | -30 | -28 | -29 | -29 | -13 | -31 | -25 | -26 | -31 | -32 | -31 | -25 | 9.5 | -13 | 2.4 | 16 | -11 | -15 | -22 | -20 | -11 | -12 | -11 | -4.2 | -6.2 | -6.3 | -3.1 | -20 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.